Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Other

OpenAI introduces GPT-Rosalind, its drug discovery AI

 April 17, 2026

Pharmaphorum

In this week’s second AI model launch for life sciences research, OpenAI has introduced GPT-Rosalind, named after UK scientist Rosalind Franklin.

OtherRead full story

Post navigation

Novo may have muscle advantage over Lilly in weight-loss race: preprint →
← RFK Jr. defends Makary, claims pharma ‘owns’ Congress and media

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com